Feasibility, effectiveness and cost of a decentralized HCV care model among the general population in Delhi, India-Reference-Cited by-同舟云学术

Feasibility, effectiveness and cost of a decentralized HCV care model among the general population in Delhi, India

Published:2021-11-29 Issue: Volume: Page:
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int

Author:

Markby Jessica¹,Gupta Ekta²^ORCID,Soni Divya³,Sarin Sanjay³,Murya Mugil³,Katapur Preetishirin³,Tewatia Navneet³,Ramachandran Babu Entoor³,Ruiz Ryan Jose¹,Gaeddert Mary⁴,Tyshkovskiy Alexander⁵⁶,Adee Madeline⁷,Chhatwal Jagpreet⁷,Miglani Sundeep⁸,Easterbrook Philippa⁹,Sarin Shiv K.²^ORCID,Shilton Sonjelle¹^ORCID

Affiliation:

1. FIND Geneva Switzerland

2. The Institute of Liver and Biliary Sciences New Delhi India

3. FIND New Delhi India

4. Division of Infectious Disease and Tropical Medicine University Hospital Heidelberg Heidelberg Germany

5. Belozersky Institute of Physico‐Chemical Biology Moscow State University Moscow Russia

6. Division of Genetics, Department of Medicine Brigham and Women’s Hospital, Harvard Medical School Boston Massachusetts USA

7. Institute for Technology Assessment Massachusetts General Hospital, Harvard Medical School Boston Massachusetts USA

8. Directorate General of Health Services Government NCT of Delhi New Delhi India

9. Department of Global HIV, Hepatitis and STI Programmes Geneva World Health Organization Geneva Switzerland

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/liv.15112

Reference12 articles.

1. World Health OrganizationGuidelines on Hepatitis B and C testing. Available athttp://www.who.int/hepatitis/publications/guidelines‐hepatitis‐c‐b‐testing/en/Accessed 24 February

2. A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt;Sievert W;Liver Int,2011

3. Future of therapy for hepatitis C in India: a matter of accessibility and affordability?;Dhiman RK;J Clin Exp Hepatol,2014

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Liver diseases and hepatocellular carcinoma in the Asia-Pacific region: burden, trends, challenges and future directions;Nature Reviews Gastroenterology & Hepatology;2024-08-15

2. Post‐Diagnosis HCV RNA Testing Rates Prior to HCV Treatment Among People Living With HIV With HCV Antibody Positivity in the Asia‐Pacific Region;Journal of Viral Hepatitis;2024-08-08

3. Decentralised same day test and treatment of hepatitis C levering existing peer support networks among men who inject drugs: feasibility and effectiveness;Harm Reduction Journal;2024-05-20

4. Molecular point of care testing for hepatitis C: available technologies, pipeline and promising future directions;The Journal of Infectious Diseases;2023-10-28

5. Low disease awareness as a contributing factor to the high prevalence of hepatitis C infection in Tzukuan, a hyperendemic area of southern Taiwan;The Kaohsiung Journal of Medical Sciences;2022-04-29